LUPIN:NSE
Lupin Ltd
₹1.953,60
arrow_upward
+0,96%(+18,60) 1D
13 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LUPIN...
Open
₹1.935,00
High
₹1.958,40
Low
₹1.926,50
Mkt. cap
894,80 ຕື້
Avg. vol.
700,70 ພັນ
Volume
739,31 ພັນ
Dividend
0,92%
Quarterly dividend
₹4,50
Ex-dividend date
17 ກ.ລ. 2026
P/E ratio
15,27
52-wk high
₹2.529,50
52-wk low
₹1.900,00
EPS
₹127,94
Shares outstanding
452,41 ລ້ານ
No. of employees
26 ພັນ
Open
₹1.935,00
High
₹1.958,40
Low
₹1.926,50
Mkt. cap
894,80 ຕື້
Avg. vol.
700,70 ພັນ
Volume
739,31 ພັນ
Dividend
0,92%
Quarterly dividend
₹4,50
Ex-dividend date
17 ກ.ລ. 2026
P/E ratio
15,27
52-wk high
₹2.529,50
52-wk low
₹1.900,00
EPS
₹127,94
Shares outstanding
452,41 ລ້ານ
No. of employees
26 ພັນ
News stories
From web sources and news partners
Morningstar
·
56 ນາທີກ່ອນ
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales and Shipments of 1.4 Million Gallons of Renewable Diesel in September
FinancialContent
·
26 ນາທີກ່ອນ
Albertsons (NYSE:ACI) Reports Q3 CY2026 In Line With Expectations
Stock Titan
·
26 ນາທີກ່ອນ
Nasdaq closed Immutep's listing case after 10 business days meeting the $1 bid minimum.
24/7 Wall St.
·
1 ຊົ່ວໂມງກ່ອນ
Buffett Says a Know-Nothing Investor Can Beat the Pros. $250 a Month in the S&P 500 Could Turn Into $508,000
Profile
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
About Lupin Ltd
CEOVinita D. Gupta
Employees26 ພັນ
Founded1968
Headquartersມຸມໄບ, ມະຫາຣາສຈຕຣະ, ອິນເດຍ
SectorPharmaceutical industry
Websitelupin.com